• Biosimilars
  • Drug Development/R&D
  • All Topics
OHE OHE
Newsletter SignupSubscribe

News & Insights
  • News
  • Events
  • Insights
  • Bulletin
  • News
  • Events
  • Insights
  • Bulletin

News & Insights

  • News
  • Events
  • Insights
  • Bulletin
Newsletter SignupSubscribe
  • News
  • Events
  • Insights
  • Bulletin

Close
OHE OHE
  • Research & Publications
  • News & Insights
  • Education
  • Innovation Policy Prize
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe

Research & Publications

All Publications

Filter by:
  • Antimicrobial Resistance (AMR)
  • Biosimilars
  • Cell and Gene Therapies
  • Chronic Diseases
  • Combination Therapies
  • COVID-19 Research
  • Digital Health
  • Drug Development/R&D
  • Emerging Markets
  • EQ-5D and PROMs
  • Health Care Systems
  • Health Data and Statistics
  • Health Technology Assessment
  • Precision Medicine
  • Real World Evidence
  • Use of Medicines
  • Value-Based Pricing
  • Vaccine Research
  • Economics of Innovation
  • Measuring and Valuing Outcomes
  • Policy, Organisation and Incentives in Health Systems
  • Value, Affordability and Decision Making

News & Insights

  • News
  • Events
  • Insights
  • Bulletin

Education

  • Education Hub
  • OHE Graduate School
  • EVIA Programme

Innovation Policy Prize

  • The Prize Fund
  • 2022 Prize Fund

Latest Research & Publications

Proposal for a General Outcome-based Value Attribution Framework for Combination Therapies

CombTher_Adobe_photoguns_portrait
Read more
© photoguns
  • Digital Health

Navigating the Landscape of Digital Health – United Kingdom

Healthcare_Adobe_elenabsl
Read more

2021 OHE Annual Report to the Charity Commission

charityreport_lina-trochez-unsplash_landscape
Read more
© Lina Trochez/Unsplash

Supporting the Era of Green Pharmaceuticals in the UK

Sustainability_AdobeStock_270582392_landscape
Read more

Quality of life and wellbeing in individuals with experience of fertility problems and assisted reproductive techniques

Quality of life assisted reproduction Cover
Read more
  • Cell and Gene Therapies
  • Value, Affordability, and…

Health Technology Assessment of Gene Therapies: Are Our Methods Fit for Purpose?

gene_therapies_national-cancer-institute-unsplash_landscape
Read more
© NCI/Unsplash
  • Drug Development/R&D
  • Economics of Innovation
  • Health Policy and Regulation

Limitations of CBO’s Simulation Model of New Drug Development as a Tool for Policymakers

CBO-US_mayer-tawfik-K4Ckc0AxgDI-unsplash_landscape
Read more
© Mayer Tawfik/Unsplash
  • Measuring and Valuing Outcomes

When Generic Measures Fail to Reflect What Matters to Patients: Three Case Studies

PROMS_unsplash_National Cancer Institute_landscape
Read more
© NCI/Unsplash
Close
OHE
  • All Publications

    Filter by:
    • Antimicrobial Resistance (AMR)
    • Biosimilars
    • Cell and Gene Therapies
    • Chronic Diseases
    • Combination Therapies
    • COVID-19 Research
    • Digital Health
    • Drug Development/R&D
    • Emerging Markets
    • EQ-5D and PROMs
    • Health Care Systems
    • Health Data and Statistics
    • Health Technology Assessment
    • Precision Medicine
    • Real World Evidence
    • Use of Medicines
    • Value-Based Pricing
    • Vaccine Research
    • Economics of Innovation
    • Measuring and Valuing Outcomes
    • Policy, Organisation and Incentives in Health Systems
    • Value, Affordability and Decision Making
    • News
    • Events
    • Insights
    • Bulletin
    • Education Hub
    • OHE Graduate School
    • EVIA Programme
    • The Prize Fund
    • 2022 Prize Fund
  • Events
  • About Us
  • OHE Experts
  • Contact Us
Newsletter SignupSubscribe
Back
  • News
11 min read 25th November 2012

Collected Essays by Tony Culyer on Health Economics

Just released is a collection of essays by Prof Tony Culyer, a founding father of health economics whose life’s work has been to bring clarity to health care decision making. The Humble Economist, published jointly by the University of York…

Share:
  •  Twitter
  •  LinkedIn
  •  Facebook
  • has-icon Email
Prof Tony Culyer

Just released is a collection of essays by Prof Tony Culyer, a founding father of health economics whose life’s work has been to bring clarity to health care decision making. The Humble Economist, published jointly by the University of York and the Office of Health Economics, is a distillation of Prof Culyer’s most important writings on health, health care and social decision making.

Prof Tony Culyer Prof Tony Culyer

 

The Humble Economist

Just released is a collection of essays by Prof Tony Culyer, a founding father of health economics whose life’s work has been to bring clarity to health care decision making.

The Humble Economist[1], published jointly by the University of York and the Office of Health Economics, is a distillation of Prof Culyer’s most important writings on health, health care and social decision making. These have been selected and shortened by Prof Culyer and edited by Profs Richard Cookson and Karl Claxton.

The book contains twenty-one essays divided into five themes, as follows.

Social scientists and social science. Culyer’s views on the role of social scientists are explored in this section. The central theme is that social scientists should not use their research to advocate a particular position, but to improve the quality of decisions. To this end, policy analysis should be based soundly on evidence and be explicit about social value judgments.

Extra-welfarism. A concept developed in the health context by Culyer, “extra-welfarism” goes beyond 19th and 20th century notions of “welfarism” as a basis for analysing individual wellbeing. His essays describe how non-welfare information about people’s health can contribute to informed decisions about health care.

Ethics, need and equity. Need and equity are complex ethical concepts that may mean different things to different people at different times. In the essays in this section, Culyer clearly describes the different ways that each concept can be applied in health care decision making, carefully teasing out the potential conflicts between different definitions.

Health policy. Culyer’s approach to health policy is to clarify objectives, then evaluate means for achieving them. The essays in this section illustrate this approach as applied to the NHS, delving into objectives and then assessing the appropriate role of market mechanisms in achieving those objectives.

Health technology assessment. This section presents essays illustrating Culyer’s three main intellectual contributions to health technology assessment: developing indicators of health that cross diseases, thinking that ultimately produced the QALY; clarifying the interplay between social value judgments and cost effectiveness; and developing deliberative evidence-informed processes for making decisions about controversial issues at the interface of science and social values.

Prof Culyer’s connection with the OHE has been long and invaluable. He has given generously of his time and talent as chairman of both the Editorial Board, which oversees OHE’s publications programme, and the Policy Board, which sets the general substantive direction of OHE’s research programme.

Download or purchase here.

Praise for The Humble Economist

 


[1]The title is after a quote from John Maynard Keynes: “If economists could manage to get themselves thought of as humble, competent people, on a level with dentist, that would be splendid!” (Keynes, J. (1963) Essays in persuasion. London: W.W. Norton & Company Ltd.)    

 

  • Health Technology Assessment…
  • Health Policy and Regulation

Related News

  • News
  • September 2019

OHE Lunchtime Seminar: Closing the ‘Know-do’ Gap for Health Systems Reform at the Policy Level

Read more
  • News
  • August 2019

OHE Annual Lecture 2019: The Evolution of U.S. Policy Responses to the Opioid Epidemic

Read more
Figures1forpaperApr19
  • News
  • April 2019

The Value of International Volunteers’ Experience to the NHS

Read more
  • News
  • March 2019

OHE Lunchtime Seminar: Cascades of Care in Health Policy Analysis and Planning

Read more
footer_ohe_logo

Leading intellectual authority on global health economics

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

Research & Publications

News & Insights

Innovation Policy Prize

Education

Events

About Us

OHE Experts

Contact Us

Sign Up for the OHE News Bulletin

Newsletter SignupStart Sign Up

The Office of Health Economics (OHE) is a company limited by guarantee registered in England and Wales (registered number 09848965) and its registered office is at 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.

Terms & Conditions

Privacy Policy

Cookies Policy

© 2023 Website Design

An error has occurred, please try again later.An error has occurred, please try again later.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

 Twitter
 Facebook
 LinkedIn
 Copy
 Email
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Please enable Strictly Necessary Cookies first so that we can save your preferences!